Total item
Cart Subtotal
$0.00 Biological Activity
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50 = 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 24.46 mL | 122.29 mL | 244.57 mL |
| 0.5 mM | 4.89 mL | 24.46 mL | 48.91 mL |
| 1 mM | 2.45 mL | 12.23 mL | 24.46 mL |
| 5 mM | 0.49 mL | 2.45 mL | 4.89 mL |
*The above data is based on the productmolecular weight 408.88. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A16928 |
|---|---|
| Actions | Inhibitor |
| M. Wt | 408.88 |
| Formula | C23H21ClN2O3 |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1443437-74-8 |
| Synonyms | CCG203971, CCG 203971 |
| SMILES | O=C(C1CN(C(C2=CC=CC(C3=CC=CO3)=C2)=O)CCC1)NC4=CC=C(Cl)C=C4 |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy CCG-203971 | CCG-203971 Supplier | purchase | cost | manufacturer | order | distributor | buy 1443437-74-8| 1443437-74-8 Supplier | purchase 1443437-74-8 | 1443437-74-8 cost | 1443437-74-8 manufacturer | order 1443437-74-8 | 1443437-74-8 distributor
Adooq Quality Guarantee
We promise all products perform as described.